Noteworthy among these are IFNγ, which plays a role in both innate and adaptive antitumor response, and IL7, which presents antitumor effects by increasing CD8+ T-cell infiltration, and is also the subject of cancer trials (27, 28). The gene discussed is CD8A; the disease is cancer.